{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T20:30:54Z","timestamp":1788813054873,"version":"build-2803163510"},"reference-count":232,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,22]],"date-time":"2021-10-22T00:00:00Z","timestamp":1634860800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,22]],"date-time":"2021-10-22T00:00:00Z","timestamp":1634860800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002839","name":"Charit\u00e9 - Universit\u00e4tsmedizin Berlin","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002839","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Pediatr"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cardiovascular complications are the major cause of the marked morbidity and mortality associated with chronic kidney disease (CKD). The classical cardiovascular risk factors such as diabetes and hypertension undoubtedly play a role in the development of cardiovascular disease (CVD) in adult CKD patients; however, CVD is just as prominent in children with CKD who do not have these risk factors. Hence, the CKD-specific pathophysiology of CVD remains incompletely understood. In light of this, studying children with CKD presents a unique opportunity to analyze CKD-associated mechanisms of CVD more specifically and could help to unveil novel therapeutic targets.<\/jats:p><jats:p>Here, we comprehensively review the interaction of the human gut microbiome and the microbial metabolism of nutrients with host immunity and cardiovascular end-organ damage. The human gut microbiome is evolutionary conditioned and modified throughout life by endogenous factors as well as environmental factors. Chronic diseases, such as CKD, cause significant disruption to the composition and function of the gut microbiome and lead to disease-associated dysbiosis. This dysbiosis and the accompanying loss of biochemical homeostasis in the epithelial cells of the colon can be the result of poor diet (e.g., low-fiber intake), medications, and underlying disease. As a result of dysbiosis, bacteria promoting proteolytic fermentation increase and those for saccharolytic fermentation decrease and the integrity of the gut barrier is perturbed (leaky gut). These changes disrupt local metabolite homeostasis in the gut and decrease productions of the beneficial short-chain fatty acids (SCFAs). Moreover, the enhanced proteolytic fermentation generates unhealthy levels of microbially derived toxic metabolites, which further accumulate in the systemic circulation as a consequence of impaired kidney function. We describe possible mechanisms involved in the increased systemic inflammation in CKD that is associated with the combined effect of SCFA deficiency and accumulation of uremic toxins. In the future, a more comprehensive and mechanistic understanding of the gut\u2013kidney\u2013heart interaction, mediated largely by immune dysregulation and inflammation, might allow us to target the gut microbiome more specifically in order to attenuate CKD-associated comorbidities.<\/jats:p>","DOI":"10.1186\/s40348-021-00126-8","type":"journal-article","created":{"date-parts":[[2021,10,22]],"date-time":"2021-10-22T13:03:36Z","timestamp":1634907816000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Bacterial metabolites and cardiovascular risk in children with chronic kidney disease"],"prefix":"10.1186","volume":"8","author":[{"given":"Julia","family":"Schlender","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Behrens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"McParland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Wilck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrik","family":"Bartolomaeus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8032-4096","authenticated-orcid":false,"given":"Johannes","family":"Holle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,22]]},"reference":[{"issue":"4 Pt 1","key":"126_CR1","doi-asserted-by":"publisher","first-page":"e382","DOI":"10.1542\/peds.111.4.e382","volume":"111","author":"G Ardissino","year":"2003","unstructured":"Ardissino G, Dacco V, Testa S, Bonaudo R, Claris-Appiani A, Taioli E et al (2003) Epidemiology of chronic renal failure in children: data from the ItalKid project. Pediatrics. 111(4 Pt 1):e382\u2013e387","journal-title":"Pediatrics."},{"issue":"2","key":"126_CR2","first-page":"130","volume":"15","author":"RM Hamed","year":"2002","unstructured":"Hamed RM (2002) The spectrum of chronic renal failure among Jordanian children. J Nephrol 15(2):130\u2013135","journal-title":"J Nephrol"},{"issue":"5","key":"126_CR3","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1053\/j.ajkd.2018.07.005","volume":"72","author":"SY Ahn","year":"2018","unstructured":"Ahn SY, Moxey-Mims M (2018) CKD in children: the importance of a national epidemiologic study. Am J Kidney Dis 72(5):628\u2013630","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"126_CR4","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1681\/ASN.2011111115","volume":"23","author":"MM Mitsnefes","year":"2012","unstructured":"Mitsnefes MM (2012) Cardiovascular disease in children with chronic kidney disease. J Am Soc Nephrol 23(4):578\u2013585","journal-title":"J Am Soc Nephrol"},{"issue":"9889","key":"126_CR5","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/S0140-6736(13)60595-4","volume":"382","author":"RT Gansevoort","year":"2013","unstructured":"Gansevoort RT, Correa-Rotter R, Hemmelgarn BR, Jafar TH, Heerspink HJ, Mann JF et al (2013) Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet. 382(9889):339\u2013352","journal-title":"Lancet."},{"issue":"26","key":"126_CR6","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.1056\/NEJMoa031643","volume":"350","author":"SP McDonald","year":"2004","unstructured":"McDonald SP, Craig JC, Australian, New Zealand Paediatric Nephrology A (2004) Long-term survival of children with end-stage renal disease. N Engl J Med 350(26):2654\u20132662","journal-title":"N Engl J Med"},{"issue":"18","key":"126_CR7","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1001\/jama.2013.4208","volume":"309","author":"MM Mitsnefes","year":"2013","unstructured":"Mitsnefes MM, Laskin BL, Dahhou M, Zhang X, Foster BJ (2013) Mortality risk among children initially treated with dialysis for end-stage kidney disease, 1990-2010. JAMA. 309(18):1921\u20131929","journal-title":"JAMA."},{"issue":"1","key":"126_CR8","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1161\/01.CIR.0000020222.63035.C0","volume":"106","author":"J Oh","year":"2002","unstructured":"Oh J, Wunsch R, Turzer M, Bahner M, Raggi P, Querfeld U et al (2002) Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation. 106(1):100\u2013105","journal-title":"Circulation."},{"issue":"4","key":"126_CR9","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/nrneph.2009.10","volume":"5","author":"MR Lilien","year":"2009","unstructured":"Lilien MR, Groothoff JW (2009) Cardiovascular disease in children with CKD or ESRD. Nat Rev Nephrol 5(4):229\u2013235","journal-title":"Nat Rev Nephrol"},{"issue":"24","key":"126_CR10","doi-asserted-by":"publisher","first-page":"2710","DOI":"10.1161\/CIRCULATIONAHA.106.179568","volume":"114","author":"RE Kavey","year":"2006","unstructured":"Kavey RE, Allada V, Daniels SR, Hayman LL, McCrindle BW, Newburger JW et al (2006) Cardiovascular risk reduction in high-risk pediatric patients: a scientific statement from the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics. Circulation 114(24):2710\u20132738","journal-title":"Circulation"},{"issue":"6","key":"126_CR11","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.semnephrol.2018.08.002","volume":"38","author":"DJ Weaver","year":"2018","unstructured":"Weaver DJ, Mitsnefes M (2018) Cardiovascular disease in children and adolescents with chronic kidney disease. Semin Nephrol 38(6):559\u2013569","journal-title":"Semin Nephrol"},{"issue":"10","key":"126_CR12","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1007\/s00467-006-0159-6","volume":"21","author":"M Civilibal","year":"2006","unstructured":"Civilibal M, Caliskan S, Adaletli I, Oflaz H, Sever L, Candan C et al (2006) Coronary artery calcifications in children with end-stage renal disease. Pediatr Nephrol 21(10):1426\u20131433","journal-title":"Pediatr Nephrol"},{"issue":"2","key":"126_CR13","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1007\/s00467-004-1718-3","volume":"20","author":"MR Lilien","year":"2005","unstructured":"Lilien MR, Koomans HA, Schroder CH (2005) Hemodialysis acutely impairs endothelial function in children. Pediatr Nephrol 20(2):200\u2013204","journal-title":"Pediatr Nephrol"},{"issue":"2","key":"126_CR14","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1038\/ki.1997.354","volume":"52","author":"JA Kari","year":"1997","unstructured":"Kari JA, Donald AE, Vallance DT, Bruckdorfer KR, Leone A, Mullen MJ et al (1997) Physiology and biochemistry of endothelial function in children with chronic renal failure. Kidney Int 52(2):468\u2013472","journal-title":"Kidney Int"},{"issue":"9","key":"126_CR15","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1093\/ndt\/gfg414","volume":"18","author":"GM London","year":"2003","unstructured":"London GM, Guerin AP, Marchais SJ, Metivier F, Pannier B, Adda H (2003) Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 18(9):1731\u20131740","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"126_CR16","doi-asserted-by":"publisher","first-page":"262","DOI":"10.5414\/CN108489","volume":"83","author":"A Kaddourah","year":"2015","unstructured":"Kaddourah A, Uthup S, Madueme P, O'Rourke M, Hooper DK, Taylor MD et al (2015) Prevalence and predictors of aortic dilation as a novel cardiovascular complication in children with end-stage renal disease. Clin Nephrol 83(5):262\u2013271","journal-title":"Clin Nephrol"},{"issue":"3","key":"126_CR17","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1053\/j.ajkd.2010.08.030","volume":"57","author":"MF Rubin","year":"2011","unstructured":"Rubin MF, Rosas SE, Chirinos JA, Townsend RR (2011) Surrogate markers of cardiovascular disease in CKD: what\u2019s under the hood? Am J Kidney Dis 57(3):488\u2013497","journal-title":"Am J Kidney Dis"},{"issue":"12","key":"126_CR18","doi-asserted-by":"publisher","first-page":"2953","DOI":"10.1097\/01.ASN.0000037677.16961.DF","volume":"13","author":"JW Groothoff","year":"2002","unstructured":"Groothoff JW, Gruppen MP, Offringa M, de Groot E, Stok W, Bos WJ et al (2002) Increased arterial stiffness in young adults with end-stage renal disease since childhood. J Am Soc Nephrol 13(12):2953\u20132961","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"126_CR19","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1053\/j.ajkd.2012.07.018","volume":"60","author":"CJ Wong","year":"2012","unstructured":"Wong CJ, Moxey-Mims M, Jerry-Fluker J, Warady BA, Furth SL (2012) CKiD (CKD in children) prospective cohort study: a review of current findings. Am J Kidney Dis 60(6):1002\u20131011","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"126_CR20","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1056\/NEJM199901143400207","volume":"340","author":"R Ross","year":"1999","unstructured":"Ross R (1999) Atherosclerosis--an inflammatory disease. N Engl J Med 340(2):115\u2013126","journal-title":"N Engl J Med"},{"issue":"12","key":"126_CR21","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","volume":"377","author":"PM Ridker","year":"2017","unstructured":"Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C et al (2017) Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med 377(12):1119\u20131131","journal-title":"N Engl J Med"},{"issue":"5","key":"126_CR22","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.2215\/CJN.00950208","volume":"3","author":"S Kato","year":"2008","unstructured":"Kato S, Chmielewski M, Honda H, Pecoits-Filho R, Matsuo S, Yuzawa Y et al (2008) Aspects of immune dysfunction in end-stage renal disease. Clin J Am Soc Nephrol 3(5):1526\u20131533","journal-title":"Clin J Am Soc Nephrol"},{"issue":"7341","key":"126_CR23","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature09922","volume":"472","author":"Z Wang","year":"2011","unstructured":"Wang Z, Klipfell E, Bennett BJ, Koeth R, Levison BS, Dugar B et al (2011) Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature. 472(7341):57\u201363","journal-title":"Nature."},{"issue":"2","key":"126_CR24","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.atherosclerosis.2013.05.019","volume":"229","author":"J Stock","year":"2013","unstructured":"Stock J (2013) Gut microbiota: an environmental risk factor for cardiovascular disease. Atherosclerosis. 229(2):440\u2013442","journal-title":"Atherosclerosis."},{"issue":"7341","key":"126_CR25","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/472040a","volume":"472","author":"K Rak","year":"2011","unstructured":"Rak K, Rader DJ (2011) Cardiovascular disease: the diet-microbe morbid union. Nature. 472(7341):40\u201341","journal-title":"Nature."},{"issue":"8","key":"126_CR26","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1111\/j.1440-1797.2012.01647.x","volume":"17","author":"F Wang","year":"2012","unstructured":"Wang F, Jiang H, Shi K, Ren Y, Zhang P, Cheng S (2012) Gut bacterial translocation is associated with microinflammation in end-stage renal disease patients. Nephrology (Carlton) 17(8):733\u2013738","journal-title":"Nephrology (Carlton)"},{"key":"126_CR27","doi-asserted-by":"publisher","unstructured":"Velasquez MT, Centron P, Barrows I, Dwivedi R, Raj DS\u00a0(2018) Gut microbiota and cardiovascular uremic toxicities. Toxins 10(7):287. https:\/\/doi.org\/10.3390\/toxins10070287","DOI":"10.3390\/toxins10070287"},{"issue":"7","key":"126_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0132589","volume":"10","author":"CJ Lin","year":"2015","unstructured":"Lin CJ, Wu V, Wu PC, Wu CJ (2015) Meta-analysis of the associations of p-cresyl sulfate (PCS) and indoxyl sulfate (IS) with cardiovascular events and all-cause mortality in patients with chronic renal failure. PLoS One 10(7):e0132589","journal-title":"PLoS One"},{"issue":"1","key":"126_CR29","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s40168-016-0222-x","volume":"5","author":"J Li","year":"2017","unstructured":"Li J, Zhao F, Wang Y, Chen J, Tao J, Tian G et al (2017) Gut microbiota dysbiosis contributes to the development of hypertension. Microbiome. 5(1):14","journal-title":"Microbiome."},{"issue":"1","key":"126_CR30","doi-asserted-by":"publisher","first-page":"3786","DOI":"10.1038\/s41598-021-83383-x","volume":"11","author":"PH Wu","year":"2021","unstructured":"Wu PH, Lin YT, Chiu YW, Baldanzi G, Huang JC, Liang SS et al (2021) The relationship of indoxyl sulfate and p-cresyl sulfate with target cardiovascular proteins in hemodialysis patients. Sci Rep 11(1):3786","journal-title":"Sci Rep"},{"issue":"5","key":"126_CR31","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1093\/ndt\/gfv095","volume":"31","author":"ND Vaziri","year":"2016","unstructured":"Vaziri ND, Zhao YY, Pahl MV (2016) Altered intestinal microbial flora and impaired epithelial barrier structure and function in CKD: the nature, mechanisms, consequences and potential treatment. Nephrol Dial Transplant 31(5):737\u2013746","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"126_CR32","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s40168-020-00875-0","volume":"8","author":"G Berg","year":"2020","unstructured":"Berg G, Rybakova D, Fischer D, Cernava T, Verges MC, Charles T et al (2020) Microbiome definition re-visited: old concepts and new challenges. Microbiome. 8(1):103","journal-title":"Microbiome."},{"issue":"12","key":"126_CR33","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1101\/gr.096651.109","volume":"19","author":"J Peterson","year":"2009","unstructured":"Group NHW, Peterson J, Garges S, Giovanni M, McInnes P, Wang L et al (2009) The NIH Human Microbiome Project. Genome Res 19(12):2317\u20132323","journal-title":"Genome Res"},{"issue":"7164","key":"126_CR34","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1038\/nature06244","volume":"449","author":"PJ Turnbaugh","year":"2007","unstructured":"Turnbaugh PJ, Ley RE, Hamady M, Fraser-Liggett CM, Knight R, Gordon JI (2007) The human microbiome project. Nature. 449(7164):804\u2013810","journal-title":"Nature."},{"issue":"7402","key":"126_CR35","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/nature11234","volume":"486","author":"Human Microbiome Project C","year":"2012","unstructured":"Human Microbiome Project C (2012) Structure, function and diversity of the healthy human microbiome. Nature. 486(7402):207\u2013214","journal-title":"Nature."},{"issue":"5728","key":"126_CR36","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1126\/science.1110591","volume":"308","author":"PB Eckburg","year":"2005","unstructured":"Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M et al (2005) Diversity of the human intestinal microbial flora. Science. 308(5728):1635\u20131638","journal-title":"Science."},{"issue":"6141","key":"126_CR37","doi-asserted-by":"publisher","first-page":"1237439","DOI":"10.1126\/science.1237439","volume":"341","author":"JJ Faith","year":"2013","unstructured":"Faith JJ, Guruge JL, Charbonneau M, Subramanian S, Seedorf H, Goodman AL et al (2013) The long-term stability of the human gut microbiota. Science. 341(6141):1237439","journal-title":"Science."},{"key":"126_CR38","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/msb4100153","volume":"3","author":"FP Martin","year":"2007","unstructured":"Martin FP, Dumas ME, Wang Y, Legido-Quigley C, Yap IK, Tang H et al (2007) A top-down systems biology view of microbiome-mammalian metabolic interactions in a mouse model. Mol Syst Biol 3:112","journal-title":"Mol Syst Biol"},{"issue":"6","key":"126_CR39","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.immuni.2014.05.015","volume":"40","author":"PC Dorrestein","year":"2014","unstructured":"Dorrestein PC, Mazmanian SK, Knight R (2014) Finding the missing links among metabolites, microbes, and the host. Immunity. 40(6):824\u2013832","journal-title":"Immunity."},{"issue":"7285","key":"126_CR40","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nature08821","volume":"464","author":"J Qin","year":"2010","unstructured":"Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C et al (2010) A human gut microbial gene catalogue established by metagenomic sequencing. Nature. 464(7285):59\u201365","journal-title":"Nature."},{"issue":"7674","key":"126_CR41","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/nature23889","volume":"550","author":"J Lloyd-Price","year":"2017","unstructured":"Lloyd-Price J, Mahurkar A, Rahnavard G, Crabtree J, Orvis J, Hall AB et al (2017) Strains, functions and dynamics in the expanded Human Microbiome Project. Nature. 550(7674):61\u201366","journal-title":"Nature."},{"issue":"7402","key":"126_CR42","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/nature11053","volume":"486","author":"T Yatsunenko","year":"2012","unstructured":"Yatsunenko T, Rey FE, Manary MJ, Trehan I, Dominguez-Bello MG, Contreras M et al (2012) Human gut microbiome viewed across age and geography. Nature. 486(7402):222\u2013227","journal-title":"Nature."},{"issue":"2","key":"126_CR43","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.arr.2009.10.004","volume":"9","author":"K Tiihonen","year":"2010","unstructured":"Tiihonen K, Ouwehand AC, Rautonen N (2010) Human intestinal microbiota and healthy ageing. Ageing Res Rev 9(2):107\u2013116","journal-title":"Ageing Res Rev"},{"key":"126_CR44","doi-asserted-by":"publisher","unstructured":"Kennedy KM, Gerlach MJ, Adam T, Heimesaat MM, Rossi L, Surette MG et al (2021) Fetal meconium does not have a detectable microbiota before birth. Nat Microbiol 6(7):865\u2013873. https:\/\/doi.org\/10.1038\/s41564-021-00904-0. Epub 2021 May 10","DOI":"10.1038\/s41564-021-00904-0"},{"issue":"6","key":"126_CR45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0158498","volume":"11","author":"R Martin","year":"2016","unstructured":"Martin R, Makino H, Cetinyurek Yavuz A, Ben-Amor K, Roelofs M, Ishikawa E et al (2016) Early-life events, including mode of delivery and type of feeding, siblings and gender, shape the developing gut microbiota. PLoS One 11(6):e0158498","journal-title":"PLoS One"},{"issue":"4","key":"126_CR46","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1136\/gutjnl-2012-303249","volume":"63","author":"HE Jakobsson","year":"2014","unstructured":"Jakobsson HE, Abrahamsson TR, Jenmalm MC, Harris K, Quince C, Jernberg C et al (2014) Decreased gut microbiota diversity, delayed Bacteroidetes colonisation and reduced Th1 responses in infants delivered by caesarean section. Gut. 63(4):559\u2013566","journal-title":"Gut."},{"issue":"6","key":"126_CR47","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1053\/j.gastro.2011.02.011","volume":"140","author":"MG Dominguez-Bello","year":"2011","unstructured":"Dominguez-Bello MG, Blaser MJ, Ley RE, Knight R (2011) Development of the human gastrointestinal microbiota and insights from high-throughput sequencing. Gastroenterology. 140(6):1713\u20131719","journal-title":"Gastroenterology."},{"issue":"5","key":"126_CR48","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1136\/gut.2006.100164","volume":"56","author":"J Penders","year":"2007","unstructured":"Penders J, Thijs C, van den Brandt PA, Kummeling I, Snijders B, Stelma F et al (2007) Gut microbiota composition and development of atopic manifestations in infancy: the KOALA Birth Cohort Study. Gut. 56(5):661\u2013667","journal-title":"Gut."},{"issue":"1","key":"126_CR49","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1053\/j.gastro.2020.08.053","volume":"160","author":"K Vu","year":"2021","unstructured":"Vu K, Lou W, Tun HM, Konya TB, Morales-Lizcano N, Chari RS et al (2021) From birth to overweight and atopic disease: multiple and common pathways of the infant gut microbiome. Gastroenterology. 160(1):128\u2013144 e10","journal-title":"Gastroenterology."},{"issue":"1","key":"126_CR50","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1136\/gut.2010.219683","volume":"60","author":"A Hviid","year":"2011","unstructured":"Hviid A, Svanstrom H, Frisch M (2011) Antibiotic use and inflammatory bowel diseases in childhood. Gut. 60(1):49\u201354","journal-title":"Gut."},{"issue":"7122","key":"126_CR51","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1038\/4441022a","volume":"444","author":"RE Ley","year":"2006","unstructured":"Ley RE, Turnbaugh PJ, Klein S, Gordon JI (2006) Microbial ecology: human gut microbes associated with obesity. Nature. 444(7122):1022\u20131023","journal-title":"Nature."},{"issue":"7122","key":"126_CR52","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1038\/nature05414","volume":"444","author":"PJ Turnbaugh","year":"2006","unstructured":"Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI (2006) An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 444(7122):1027\u20131031","journal-title":"Nature."},{"issue":"9","key":"126_CR53","doi-asserted-by":"publisher","first-page":"2891","DOI":"10.1111\/1462-2920.12238","volume":"16","author":"T Jost","year":"2014","unstructured":"Jost T, Lacroix C, Braegger CP, Rochat F, Chassard C (2014) Vertical mother-neonate transfer of maternal gut bacteria via breastfeeding. Environ Microbiol 16(9):2891\u20132904","journal-title":"Environ Microbiol"},{"issue":"7","key":"126_CR54","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1080\/10408398.2020.1754756","volume":"61","author":"L Cheng","year":"2021","unstructured":"Cheng L, Akkerman R, Kong C, Walvoort MTC, de Vos P (2021) More than sugar in the milk: human milk oligosaccharides as essential bioactive molecules in breast milk and current insight in beneficial effects. Crit Rev Food Sci Nutr 61(7):1184\u20131200","journal-title":"Crit Rev Food Sci Nutr"},{"key":"126_CR55","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.mad.2019.02.001","volume":"179","author":"N Tuikhar","year":"2019","unstructured":"Tuikhar N, Keisam S, Labala RK, Imrat RP, Arunkumar MC et al (2019) Comparative analysis of the gut microbiota in centenarians and young adults shows a common signature across genotypically non-related populations. Mech Ageing Dev 179:23\u201335","journal-title":"Mech Ageing Dev"},{"key":"126_CR56","doi-asserted-by":"publisher","first-page":"258","DOI":"10.3389\/fphar.2020.00258","volume":"11","author":"G Silveira-Nunes","year":"2020","unstructured":"Silveira-Nunes G, Durso DF, Olieveira L Jr, Cunha EHM, Maioli TU, Vieira AT et al (2020) Hypertension is associated with intestinal microbiota dysbiosis and inflammation in a Brazilian population. Front Pharmacol 11:258","journal-title":"Front Pharmacol"},{"key":"126_CR57","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/1471-2180-9-123","volume":"9","author":"D Mariat","year":"2009","unstructured":"Mariat D, Firmesse O, Levenez F, Guimaraes V, Sokol H, Dore J et al (2009) The Firmicutes\/Bacteroidetes ratio of the human microbiota changes with age. BMC Microbiol 9:123","journal-title":"BMC Microbiol"},{"issue":"6","key":"126_CR58","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1161\/HYPERTENSIONAHA.115.05315","volume":"65","author":"T Yang","year":"2015","unstructured":"Yang T, Santisteban MM, Rodriguez V, Li E, Ahmari N, Carvajal JM et al (2015) Gut dysbiosis is linked to hypertension. Hypertension. 65(6):1331\u20131340","journal-title":"Hypertension."},{"issue":"1","key":"126_CR59","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1038\/s41598-020-57734-z","volume":"10","author":"D Radjabzadeh","year":"2020","unstructured":"Radjabzadeh D, Boer CG, Beth SA, van der Wal P, Kiefte-De Jong JC, Jansen MAE et al (2020) Diversity, compositional and functional differences between gut microbiota of children and adults. Sci Rep 10(1):1040","journal-title":"Sci Rep"},{"issue":"7415","key":"126_CR60","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/nature11552","volume":"489","author":"V Tremaroli","year":"2012","unstructured":"Tremaroli V, Backhed F (2012) Functional interactions between the gut microbiota and host metabolism. Nature. 489(7415):242\u2013249","journal-title":"Nature."},{"issue":"5","key":"126_CR61","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.chom.2015.04.006","volume":"17","author":"P Vangay","year":"2015","unstructured":"Vangay P, Ward T, Gerber JS, Knights D (2015) Antibiotics, pediatric dysbiosis, and disease. Cell Host Microbe 17(5):553\u2013564","journal-title":"Cell Host Microbe"},{"issue":"3","key":"126_CR62","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1093\/aje\/kwq400","volume":"173","author":"KR Risnes","year":"2011","unstructured":"Risnes KR, Belanger K, Murk W, Bracken MB (2011) Antibiotic exposure by 6 months and asthma and allergy at 6 years: findings in a cohort of 1,401 US children. Am J Epidemiol 173(3):310\u2013318","journal-title":"Am J Epidemiol"},{"issue":"1","key":"126_CR63","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s13073-020-00782-x","volume":"12","author":"DJ Schwartz","year":"2020","unstructured":"Schwartz DJ, Langdon AE, Dantas G (2020) Understanding the impact of antibiotic perturbation on the human microbiome. Genome Med 12(1):82","journal-title":"Genome Med"},{"issue":"7698","key":"126_CR64","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/nature25979","volume":"555","author":"L Maier","year":"2018","unstructured":"Maier L, Pruteanu M, Kuhn M, Zeller G, Telzerow A, Anderson EE et al (2018) Extensive impact of non-antibiotic drugs on human gut bacteria. Nature. 555(7698):623\u2013628","journal-title":"Nature."},{"issue":"1","key":"126_CR65","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/s41467-019-14177-z","volume":"11","author":"A Vich Vila","year":"2020","unstructured":"Vich Vila A, Collij V, Sanna S, Sinha T, Imhann F, Bourgonje AR et al (2020) Impact of commonly used drugs on the composition and metabolic function of the gut microbiota. Nat Commun 11(1):362","journal-title":"Nat Commun"},{"issue":"7682","key":"126_CR66","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/nature24628","volume":"551","author":"N Wilck","year":"2017","unstructured":"Wilck N, Matus MG, Kearney SM, Olesen SW, Forslund K, Bartolomaeus H et al (2017) Salt-responsive gut commensal modulates TH17 axis and disease. Nature. 551(7682):585\u2013589","journal-title":"Nature."},{"issue":"3","key":"126_CR67","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/s41581-020-00345-8","volume":"17","author":"D Mafra","year":"2021","unstructured":"Mafra D, Borges NA, Lindholm B, Shiels PG, Evenepoel P, Stenvinkel P (2021) Food as medicine: targeting the uraemic phenotype in chronic kidney disease. Nat Rev Nephrol 17(3):153\u2013171","journal-title":"Nat Rev Nephrol"},{"issue":"7521","key":"126_CR68","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/nature13793","volume":"514","author":"J Suez","year":"2014","unstructured":"Suez J, Korem T, Zeevi D, Zilberman-Schapira G, Thaiss CA, Maza O et al (2014) Artificial sweeteners induce glucose intolerance by altering the gut microbiota. Nature. 514(7521):181\u2013186","journal-title":"Nature."},{"issue":"2","key":"126_CR69","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/ki.2012.345","volume":"83","author":"ND Vaziri","year":"2013","unstructured":"Vaziri ND, Wong J, Pahl M, Piceno YM, Yuan J, DeSantis TZ et al (2013) Chronic kidney disease alters intestinal microbial flora. Kidney Int 83(2):308\u2013315","journal-title":"Kidney Int"},{"issue":"4","key":"126_CR70","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/nri.2017.7","volume":"17","author":"M Levy","year":"2017","unstructured":"Levy M, Kolodziejczyk AA, Thaiss CA, Elinav E (2017) Dysbiosis and the immune system. Nat Rev Immunol 17(4):219\u2013232","journal-title":"Nat Rev Immunol"},{"key":"126_CR71","doi-asserted-by":"publisher","first-page":"604179","DOI":"10.3389\/fimmu.2020.604179","volume":"11","author":"A Rutsch","year":"2020","unstructured":"Rutsch A, Kantsjo JB, Ronchi F (2020) The gut-brain axis: how microbiota and host inflammasome influence brain physiology and pathology. Front Immunol 11:604179","journal-title":"Front Immunol"},{"issue":"6","key":"126_CR72","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/cmi.2018.7","volume":"15","author":"B Li","year":"2018","unstructured":"Li B, Selmi C, Tang R, Gershwin ME, Ma X (2018) The microbiome and autoimmunity: a paradigm from the gut-liver axis. Cell Mol Immunol 15(6):595\u2013609","journal-title":"Cell Mol Immunol"},{"issue":"1","key":"126_CR73","doi-asserted-by":"publisher","first-page":"3621","DOI":"10.1038\/s41467-019-11460-x","volume":"10","author":"JT Russell","year":"2019","unstructured":"Russell JT, Roesch LFW, Ordberg M, Ilonen J, Atkinson MA, Schatz DA et al (2019) Genetic risk for autoimmunity is associated with distinct changes in the human gut microbiome. Nat Commun 10(1):3621","journal-title":"Nat Commun"},{"key":"126_CR74","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.ynstr.2017.03.001","volume":"7","author":"JA Foster","year":"2017","unstructured":"Foster JA, Rinaman L, Cryan JF (2017) Stress & the gut-brain axis: regulation by the microbiome. Neurobiol Stress 7:124\u2013136","journal-title":"Neurobiol Stress"},{"issue":"7","key":"126_CR75","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1038\/s12276-020-0459-0","volume":"52","author":"R Quiroga","year":"2020","unstructured":"Quiroga R, Nistal E, Estebanez B, Porras D, Juarez-Fernandez M, Martinez-Florez S et al (2020) Exercise training modulates the gut microbiota profile and impairs inflammatory signaling pathways in obese children. Exp Mol Med 52(7):1048\u20131061","journal-title":"Exp Mol Med"},{"issue":"1","key":"126_CR76","doi-asserted-by":"publisher","first-page":"15228","DOI":"10.1038\/s41598-017-15079-0","volume":"7","author":"S Zheng","year":"2017","unstructured":"Zheng S, Shao S, Qiao Z, Chen X, Piao C, Yu Y et al (2017) Clinical parameters and gut microbiome changes before and after surgery in thoracic aortic dissection in patients with gastrointestinal complications. Sci Rep 7(1):15228","journal-title":"Sci Rep"},{"issue":"33","key":"126_CR77","doi-asserted-by":"publisher","first-page":"14691","DOI":"10.1073\/pnas.1005963107","volume":"107","author":"C De Filippo","year":"2010","unstructured":"De Filippo C, Cavalieri D, Di Paola M, Ramazzotti M, Poullet JB, Massart S et al (2010) Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci U S A 107(33):14691\u201314696","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"126_CR78","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/s42255-021-00348-0","volume":"3","author":"T Wilmanski","year":"2021","unstructured":"Wilmanski T, Diener C, Rappaport N, Patwardhan S, Wiedrick J, Lapidus J et al (2021) Gut microbiome pattern reflects healthy ageing and predicts survival in humans. Nat Metab 3(2):274\u2013286","journal-title":"Nat Metab"},{"key":"126_CR79","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.tma.2020.07.004","volume":"4","author":"M Kim","year":"2020","unstructured":"Kim M, Benayoun BA (2020) The microbiome: an emerging key player in aging and longevity. Transl Med Aging 4:103\u2013116","journal-title":"Transl Med Aging"},{"key":"126_CR80","doi-asserted-by":"publisher","unstructured":"Castillo-Rodriguez E, Fernandez-Prado R, Esteras R, Perez-Gomez MV, Gracia-Iguacel C, Fernandez-Fernandez B et al (2018) Impact of altered intestinal microbiota on chronic kidney disease progression. Toxins 10(7):300.\u00a0https:\/\/doi.org\/10.3390\/toxins10070300","DOI":"10.3390\/toxins10070300"},{"issue":"5519","key":"126_CR81","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1126\/science.1058709","volume":"292","author":"LV Hooper","year":"2001","unstructured":"Hooper LV, Gordon JI (2001) Commensal host-bacterial relationships in the gut. Science. 292(5519):1115\u20131118","journal-title":"Science."},{"issue":"3","key":"126_CR82","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1097\/MOG.0000000000000057","volume":"30","author":"JM Ridlon","year":"2014","unstructured":"Ridlon JM, Kang DJ, Hylemon PB, Bajaj JS (2014) Bile acids and the gut microbiome. Curr Opin Gastroenterol 30(3):332\u2013338","journal-title":"Curr Opin Gastroenterol"},{"issue":"7","key":"126_CR83","doi-asserted-by":"publisher","first-page":"1857S","DOI":"10.1093\/jn\/130.7.1857S","volume":"130","author":"CC Metges","year":"2000","unstructured":"Metges CC (2000) Contribution of microbial amino acids to amino acid homeostasis of the host. J Nutr 130(7):1857S\u20131864S","journal-title":"J Nutr"},{"issue":"Suppl 4","key":"126_CR84","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/jgh.12294","volume":"28","author":"BS Ramakrishna","year":"2013","unstructured":"Ramakrishna BS (2013) Role of the gut microbiota in human nutrition and metabolism. J Gastroenterol Hepatol 28(Suppl 4):9\u201317","journal-title":"J Gastroenterol Hepatol"},{"issue":"2","key":"126_CR85","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/mi.2009.132","volume":"3","author":"DA Hill","year":"2010","unstructured":"Hill DA, Hoffmann C, Abt MC, Du Y, Kobuley D, Kirn TJ et al (2010) Metagenomic analyses reveal antibiotic-induced temporal and spatial changes in intestinal microbiota with associated alterations in immune cell homeostasis. Mucosal Immunol 3(2):148\u2013158","journal-title":"Mucosal Immunol"},{"key":"126_CR86","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1111\/j.1749-6632.1959.tb53104.x","volume":"78","author":"HA Gordon","year":"1959","unstructured":"Gordon HA (1959) Morphological and physiological characterization of germfree life. Ann N Y Acad Sci 78:208\u2013220","journal-title":"Ann N Y Acad Sci"},{"issue":"6","key":"126_CR87","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1038\/ki.2012.440","volume":"83","author":"HJ Anders","year":"2013","unstructured":"Anders HJ, Andersen K, Stecher B (2013) The intestinal microbiota, a leaky gut, and abnormal immunity in kidney disease. Kidney Int 83(6):1010\u20131016","journal-title":"Kidney Int"},{"issue":"8","key":"126_CR88","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/nrm2934","volume":"11","author":"A Shevchenko","year":"2010","unstructured":"Shevchenko A, Simons K (2010) Lipidomics: coming to grips with lipid diversity. Nat Rev Mol Cell Biol 11(8):593\u2013598","journal-title":"Nat Rev Mol Cell Biol"},{"key":"126_CR89","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1146\/annurev.nutr.22.011602.092259","volume":"22","author":"LV Hooper","year":"2002","unstructured":"Hooper LV, Midtvedt T, Gordon JI (2002) How host-microbial interactions shape the nutrient environment of the mammalian intestine. Annu Rev Nutr 22:283\u2013307","journal-title":"Annu Rev Nutr"},{"issue":"2","key":"126_CR90","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.copbio.2005.01.007","volume":"16","author":"AC Ouwehand","year":"2005","unstructured":"Ouwehand AC, Derrien M, de Vos W, Tiihonen K, Rautonen N (2005) Prebiotics and other microbial substrates for gut functionality. Curr Opin Biotechnol 16(2):212\u2013217","journal-title":"Curr Opin Biotechnol"},{"issue":"2","key":"126_CR91","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1093\/advances\/nmy068","volume":"10","author":"M Snelson","year":"2019","unstructured":"Snelson M, Kellow NJ, Coughlan MT (2019) Modulation of the gut microbiota by resistant starch as a treatment of chronic kidney diseases: evidence of efficacy and mechanistic insights. Adv Nutr 10(2):303\u2013320","journal-title":"Adv Nutr"},{"issue":"12","key":"126_CR92","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.3748\/wjg.v17.i12.1519","volume":"17","author":"RB Canani","year":"2011","unstructured":"Canani RB, Costanzo MD, Leone L, Pedata M, Meli R, Calignano A (2011) Potential beneficial effects of butyrate in intestinal and extraintestinal diseases. World J Gastroenterol 17(12):1519\u20131528","journal-title":"World J Gastroenterol"},{"issue":"Suppl 2","key":"126_CR93","first-page":"251","volume":"59","author":"H Tazoe","year":"2008","unstructured":"Tazoe H, Otomo Y, Kaji I, Tanaka R, Karaki SI, Kuwahara A (2008) Roles of short-chain fatty acids receptors, GPR41 and GPR43 on colonic functions. J Physiol Pharmacol 59(Suppl 2):251\u2013262","journal-title":"J Physiol Pharmacol"},{"issue":"3","key":"126_CR94","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1152\/physrev.2001.81.3.1031","volume":"81","author":"DL Topping","year":"2001","unstructured":"Topping DL, Clifton PM (2001) Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides. Physiol Rev 81(3):1031\u20131064","journal-title":"Physiol Rev"},{"key":"126_CR95","doi-asserted-by":"publisher","unstructured":"Snelson M, Coughlan MT (2019) Dietary advanced glycation end products: digestion, metabolism and modulation of gut microbial ecology. Nutrients\u00a011(2):215. https:\/\/doi.org\/10.3390\/nu11020215","DOI":"10.3390\/nu11020215"},{"key":"126_CR96","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1146\/annurev.nu.14.070194.001501","volume":"14","author":"G Annison","year":"1994","unstructured":"Annison G, Topping DL (1994) Nutritional role of resistant starch: chemical structure vs physiological function. Annu Rev Nutr 14:297\u2013320","journal-title":"Annu Rev Nutr"},{"key":"126_CR97","doi-asserted-by":"publisher","unstructured":"Ikee R, Sasaki N, Yasuda T, Fukazawa S (2020) Chronic kidney disease, gut dysbiosis, and constipation: a burdensome triplet. Microorganisms\u00a08(12):1862. https:\/\/doi.org\/10.3390\/microorganisms8121862","DOI":"10.3390\/microorganisms8121862"},{"issue":"7331","key":"126_CR98","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/nature09646","volume":"469","author":"S Fukuda","year":"2011","unstructured":"Fukuda S, Toh H, Hase K, Oshima K, Nakanishi Y, Yoshimura K et al (2011) Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature. 469(7331):543\u2013547","journal-title":"Nature."},{"issue":"6","key":"126_CR99","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.immuni.2014.05.014","volume":"40","author":"AN Thorburn","year":"2014","unstructured":"Thorburn AN, Macia L, Mackay CR (2014) Diet, metabolites, and \u201cwestern-lifestyle\u201d inflammatory diseases. Immunity. 40(6):833\u2013842","journal-title":"Immunity."},{"issue":"2","key":"126_CR100","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1046\/j.1365-2567.1997.00337.x","volume":"92","author":"GA Bohmig","year":"1997","unstructured":"Bohmig GA, Krieger PM, Saemann MD, Wenhardt C, Pohanka E, Zlabinger GJ (1997) n-Butyrate downregulates the stimulatory function of peripheral blood-derived antigen-presenting cells: a potential mechanism for modulating T-cell responses by short-chain fatty acids. Immunology. 92(2):234\u2013243","journal-title":"Immunology."},{"issue":"6","key":"126_CR101","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1073\/pnas.1322269111","volume":"111","author":"PV Chang","year":"2014","unstructured":"Chang PV, Hao L, Offermanns S, Medzhitov R (2014) The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition. Proc Natl Acad Sci U S A 111(6):2247\u20132252","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"126_CR102","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.nut.2004.11.011","volume":"21","author":"SJ Miller","year":"2005","unstructured":"Miller SJ, Zaloga GP, Hoggatt AM, Labarrere C, Faulk WP (2005) Short-chain fatty acids modulate gene expression for vascular endothelial cell adhesion molecules. Nutrition. 21(6):740\u2013748","journal-title":"Nutrition."},{"issue":"15","key":"126_CR103","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1096\/fj.00-0359fje","volume":"14","author":"MD Saemann","year":"2000","unstructured":"Saemann MD, Bohmig GA, Osterreicher CH, Burtscher H, Parolini O, Diakos C et al (2000) Anti-inflammatory effects of sodium butyrate on human monocytes: potent inhibition of IL-12 and up-regulation of IL-10 production. FASEB J 14(15):2380\u20132382","journal-title":"FASEB J"},{"issue":"6145","key":"126_CR104","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1126\/science.1241165","volume":"341","author":"PM Smith","year":"2013","unstructured":"Smith PM, Howitt MR, Panikov N, Michaud M, Gallini CA, Bohlooly YM et al (2013) The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science. 341(6145):569\u2013573","journal-title":"Science."},{"key":"126_CR105","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.ejphar.2018.05.003","volume":"831","author":"M Li","year":"2018","unstructured":"Li M, van Esch B, Wagenaar GTM, Garssen J, Folkerts G, Henricks PAJ (2018) Pro- and anti-inflammatory effects of short chain fatty acids on immune and endothelial cells. Eur J Pharmacol 831:52\u201359","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"126_CR106","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1080\/19490976.2015.1134082","volume":"7","author":"DJ Morrison","year":"2016","unstructured":"Morrison DJ, Preston T (2016) Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism. Gut Microbes 7(3):189\u2013200","journal-title":"Gut Microbes"},{"issue":"5","key":"126_CR107","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.cmet.2011.02.018","volume":"13","author":"DR Donohoe","year":"2011","unstructured":"Donohoe DR, Garge N, Zhang X, Sun W, O'Connell TM, Bunger MK et al (2011) The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon. Cell Metab 13(5):517\u2013526","journal-title":"Cell Metab"},{"issue":"3","key":"126_CR108","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1159\/000360010","volume":"39","author":"J Wong","year":"2014","unstructured":"Wong J, Piceno YM, DeSantis TZ, Pahl M, Andersen GL, Vaziri ND (2014) Expansion of urease- and uricase-containing, indole- and p-cresol-forming and contraction of short-chain fatty acid-producing intestinal microbiota in ESRD. Am J Nephrol 39(3):230\u2013237","journal-title":"Am J Nephrol"},{"issue":"2","key":"126_CR109","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/BF01307542","volume":"38","author":"JY Kang","year":"1993","unstructured":"Kang JY (1993) The gastrointestinal tract in uremia. Dig Dis Sci 38(2):257\u2013268","journal-title":"Dig Dis Sci"},{"issue":"4","key":"126_CR110","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1681\/ASN.V641313","volume":"6","author":"ND Vaziri","year":"1995","unstructured":"Vaziri ND, Freel RW, Hatch M (1995) Effect of chronic experimental renal insufficiency on urate metabolism. J Am Soc Nephrol 6(4):1313\u20131317","journal-title":"J Am Soc Nephrol"},{"issue":"10","key":"126_CR111","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1007\/s10482-016-0737-y","volume":"109","author":"S Jiang","year":"2016","unstructured":"Jiang S, Xie S, Lv D, Zhang Y, Deng J, Zeng L et al (2016) A reduction in the butyrate producing species Roseburia spp. and Faecalibacterium prausnitzii is associated with chronic kidney disease progression. Antonie Van Leeuwenhoek 109(10):1389\u20131396","journal-title":"Antonie Van Leeuwenhoek"},{"issue":"8","key":"126_CR112","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0134311","volume":"10","author":"C Barrios","year":"2015","unstructured":"Barrios C, Beaumont M, Pallister T, Villar J, Goodrich JK, Clark A et al (2015) Gut-microbiota-metabolite axis in early renal function decline. PLoS One 10(8):e0134311","journal-title":"PLoS One"},{"key":"126_CR113","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/1471-2180-11-86","volume":"11","author":"LF Dawson","year":"2011","unstructured":"Dawson LF, Donahue EH, Cartman ST, Barton RH, Bundy J, McNerney R et al (2011) The analysis of para-cresol production and tolerance in Clostridium difficile 027 and 012 strains. BMC Microbiol 11:86","journal-title":"BMC Microbiol"},{"issue":"1","key":"126_CR114","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1128\/aem.53.1.189-192.1987","volume":"53","author":"LA Ward","year":"1987","unstructured":"Ward LA, Johnson KA, Robinson IM, Yokoyama MT (1987) Isolation from swine feces of a bacterium which decarboxylates p-hydroxyphenylacetic acid to 4-methylphenol (p-cresol). Appl Environ Microbiol 53(1):189\u2013192","journal-title":"Appl Environ Microbiol"},{"key":"126_CR115","doi-asserted-by":"publisher","unstructured":"Hsu CN, Lu PC, Hou CY, Tain YL (2019) Blood pressure abnormalities associated with gut microbiota-derived short chain fatty acids in children with congenital anomalies of the kidney and urinary tract. J Clin Med\u00a08(8):1090. https:\/\/doi.org\/10.3390\/jcm8081090","DOI":"10.3390\/jcm8081090"},{"issue":"1","key":"126_CR116","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s40168-016-0195-9","volume":"4","author":"J Crespo-Salgado","year":"2016","unstructured":"Crespo-Salgado J, Vehaskari VM, Stewart T, Ferris M, Zhang Q, Wang G et al (2016) Intestinal microbiota in pediatric patients with end stage renal disease: a Midwest Pediatric Nephrology Consortium study. Microbiome. 4(1):50","journal-title":"Microbiome."},{"issue":"6","key":"126_CR117","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1007\/s00467-016-3392-7","volume":"32","author":"S Al Khodor","year":"2017","unstructured":"Al Khodor S, Shatat IF (2017) Gut microbiome and kidney disease: a bidirectional relationship. Pediatr Nephrol 32(6):921\u2013931","journal-title":"Pediatr Nephrol"},{"issue":"2","key":"126_CR118","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ekir.2019.11.002","volume":"5","author":"K Sumida","year":"2020","unstructured":"Sumida K, Yamagata K, Kovesdy CP (2020) Constipation in CKD. Kidney Int Rep 5(2):121\u2013134","journal-title":"Kidney Int Rep"},{"issue":"11","key":"126_CR119","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1007\/s00467-016-3527-x","volume":"32","author":"P Evenepoel","year":"2017","unstructured":"Evenepoel P, Poesen R, Meijers B (2017) The gut-kidney axis. Pediatr Nephrol 32(11):2005\u20132014","journal-title":"Pediatr Nephrol"},{"issue":"5","key":"126_CR120","doi-asserted-by":"publisher","first-page":"G1429","DOI":"10.1152\/ajpgi.00315.2006","volume":"292","author":"T Ohama","year":"2007","unstructured":"Ohama T, Hori M, Momotani E, Iwakura Y, Guo F, Kishi H et al (2007) Intestinal inflammation downregulates smooth muscle CPI-17 through induction of TNF-alpha and causes motility disorders. Am J Physiol Gastrointest Liver Physiol 292(5):G1429\u2013G1438","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"1","key":"126_CR121","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.bbadis.2011.03.016","volume":"1822","author":"BY De Winter","year":"2012","unstructured":"De Winter BY, van den Wijngaard RM, de Jonge WJ (2012) Intestinal mast cells in gut inflammation and motility disturbances. Biochim Biophys Acta 1822(1):66\u201373","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"126_CR122","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1136\/gut.7.5.558","volume":"7","author":"E Bourke","year":"1966","unstructured":"Bourke E, Milne MD, Stokes GS (1966) Caecal pH and ammonia in experimental uraemia. Gut. 7(5):558\u2013561","journal-title":"Gut."},{"issue":"3","key":"126_CR123","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1007\/s002489900020","volume":"33","author":"EA Smith","year":"1997","unstructured":"Smith EA, Macfarlane GT (1997) Formation of phenolic and indolic compounds by anaerobic bacteria in the human large intestine. Microb Ecol 33(3):180\u2013188","journal-title":"Microb Ecol"},{"issue":"3","key":"126_CR124","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1111\/j.1365-2672.1996.tb04331.x","volume":"81","author":"EA Smith","year":"1996","unstructured":"Smith EA, Macfarlane GT (1996) Enumeration of human colonic bacteria producing phenolic and indolic compounds: effects of pH, carbohydrate availability and retention time on dissimilatory aromatic amino acid metabolism. J Appl Bacteriol 81(3):288\u2013302","journal-title":"J Appl Bacteriol"},{"issue":"10","key":"126_CR125","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1136\/gut.28.10.1221","volume":"28","author":"JH Cummings","year":"1987","unstructured":"Cummings JH, Pomare EW, Branch WJ, Naylor CP, Macfarlane GT (1987) Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut. 28(10):1221\u20131227","journal-title":"Gut."},{"issue":"Suppl 1","key":"126_CR126","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.1111\/hdi.12553","volume":"21","author":"GAM Kortman","year":"2017","unstructured":"Kortman GAM, Reijnders D, Swinkels DW (2017) Oral iron supplementation: potential implications for the gut microbiome and metabolome in patients with CKD. Hemodial Int 21(Suppl 1):S28\u2013S36","journal-title":"Hemodial Int"},{"issue":"12","key":"126_CR127","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1007\/s00467-019-04331-6","volume":"34","author":"J Holle","year":"2019","unstructured":"Holle J, Querfeld U, Kirchner M, Anninos A, Okun J, Thurn-Valsassina D et al (2019) Indoxyl sulfate associates with cardiovascular phenotype in children with chronic kidney disease. Pediatr Nephrol 34(12):2571\u20132582","journal-title":"Pediatr Nephrol"},{"issue":"17","key":"126_CR128","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1161\/01.CIR.0000035250.66458.67","volume":"106","author":"T Drueke","year":"2002","unstructured":"Drueke T, Witko-Sarsat V, Massy Z, Descamps-Latscha B, Guerin AP, Marchais SJ et al (2002) Iron therapy, advanced oxidation protein products, and carotid artery intima-media thickness in end-stage renal disease. Circulation. 106(17):2212\u20132217","journal-title":"Circulation."},{"issue":"13","key":"126_CR129","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1056\/NEJMra071313","volume":"357","author":"TW Meyer","year":"2007","unstructured":"Meyer TW, Hostetter TH (2007) Uremia. N Engl J Med 357(13):1316\u20131325","journal-title":"N Engl J Med"},{"issue":"5","key":"126_CR130","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1046\/j.1523-1755.2003.00924.x","volume":"63","author":"R Vanholder","year":"2003","unstructured":"Vanholder R, De Smet R, Glorieux G, Argiles A, Baurmeister U, Brunet P et al (2003) Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int 63(5):1934\u20131943","journal-title":"Kidney Int"},{"key":"126_CR131","doi-asserted-by":"publisher","unstructured":"Snauwaert E, Holvoet E, Van Biesen W, Raes A, Glorieux G, Vande Walle J et al (2019) Uremic toxin concentrations are related to residual kidney function in the pediatric hemodialysis population. Toxins 11(4):235. https:\/\/doi.org\/10.3390\/toxins11040235","DOI":"10.3390\/toxins11040235"},{"issue":"9","key":"126_CR132","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1681\/ASN.2010121220","volume":"22","author":"PA Aronov","year":"2011","unstructured":"Aronov PA, Luo FJ, Plummer NS, Quan Z, Holmes S, Hostetter TH et al (2011) Colonic contribution to uremic solutes. J Am Soc Nephrol 22(9):1769\u20131776","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"126_CR133","doi-asserted-by":"publisher","first-page":"12675","DOI":"10.1038\/s41598-020-69559-x","volume":"10","author":"Y Cheng","year":"2020","unstructured":"Cheng Y, Li Y, Benkowitz P, Lamina C, Kottgen A, Sekula P (2020) The relationship between blood metabolites of the tryptophan pathway and kidney function: a bidirectional Mendelian randomization analysis. Sci Rep 10(1):12675","journal-title":"Sci Rep"},{"key":"126_CR134","doi-asserted-by":"publisher","first-page":"117864691769460","DOI":"10.1177\/1178646917694600","volume":"10","author":"S Debnath","year":"2017","unstructured":"Debnath S, Velagapudi C, Redus L, Thameem F, Kasinath B, Hura CE et al (2017) Tryptophan metabolism in patients with chronic kidney disease secondary to type 2 diabetes: relationship to inflammatory markers. Int J Tryptophan Res 10:1178646917694600","journal-title":"Int J Tryptophan Res"},{"issue":"1","key":"126_CR135","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s12882-016-0387-3","volume":"17","author":"N Karu","year":"2016","unstructured":"Karu N, McKercher C, Nichols DS, Davies N, Shellie RA, Hilder EF et al (2016) Tryptophan metabolism, its relation to inflammation and stress markers and association with psychological and cognitive functioning: Tasmanian Chronic Kidney Disease pilot study. BMC Nephrol 17(1):171","journal-title":"BMC Nephrol"},{"key":"126_CR136","doi-asserted-by":"publisher","first-page":"836","DOI":"10.3389\/fphys.2017.00836","volume":"8","author":"B Kalaska","year":"2017","unstructured":"Kalaska B, Pawlak K, Domaniewski T, Oksztulska-Kolanek E, Znorko B, Roszczenko A et al (2017) Elevated levels of peripheral kynurenine decrease bone strength in rats with chronic kidney disease. Front Physiol 8:836","journal-title":"Front Physiol"},{"issue":"1","key":"126_CR137","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s11255-017-1729-1","volume":"50","author":"TW Kaminski","year":"2018","unstructured":"Kaminski TW, Pawlak K, Karbowska M, Mysliwiec M, Grzegorzewski W, Kuna J et al (2018) Association between uremic toxin-anthranilic acid and fibrinolytic system activity in predialysis patients at different stages of chronic kidney disease. Int Urol Nephrol 50(1):127\u2013135","journal-title":"Int Urol Nephrol"},{"key":"126_CR138","doi-asserted-by":"publisher","unstructured":"Addi T, Dou L, Burtey S (2018) Tryptophan-derived uremic toxins and thrombosis in chronic kidney disease. Toxins 10(10):412. https:\/\/doi.org\/10.3390\/toxins10100412","DOI":"10.3390\/toxins10100412"},{"issue":"1","key":"126_CR139","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13073-016-0296-x","volume":"8","author":"LS Zhang","year":"2016","unstructured":"Zhang LS, Davies SS (2016) Microbial metabolism of dietary components to bioactive metabolites: opportunities for new therapeutic interventions. Genome Med 8(1):46","journal-title":"Genome Med"},{"issue":"9","key":"126_CR140","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.2215\/CJN.00300113","volume":"8","author":"R Poesen","year":"2013","unstructured":"Poesen R, Viaene L, Verbeke K, Claes K, Bammens B, Sprangers B et al (2013) Renal clearance and intestinal generation of p-cresyl sulfate and indoxyl sulfate in CKD. Clin J Am Soc Nephrol 8(9):1508\u20131514","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"126_CR141","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1177\/1535370219826526","volume":"244","author":"MA Bryniarski","year":"2019","unstructured":"Bryniarski MA, Hamarneh F, Yacoub R (2019) The role of chronic kidney disease-associated dysbiosis in cardiovascular disease. Exp Biol Med (Maywood) 244(6):514\u2013525","journal-title":"Exp Biol Med (Maywood)"},{"key":"126_CR142","doi-asserted-by":"publisher","unstructured":"Holmar J, de la Puente-Secades S, Floege J, Noels H, Jankowski J, Orth-Alampour S (2020) Uremic toxins affecting cardiovascular calcification: a systematic review. Cells 9(11):2428. https:\/\/doi.org\/10.3390\/cells9112428","DOI":"10.3390\/cells9112428"},{"key":"126_CR143","doi-asserted-by":"publisher","unstructured":"Lim YJ, Sidor NA, Tonial NC, Che A, Urquhart BL (2021) Uremic toxins in the progression of chronic kidney disease and cardiovascular disease: mechanisms and therapeutic targets. Toxins 13(2):142. https:\/\/doi.org\/10.3390\/toxins13020142","DOI":"10.3390\/toxins13020142"},{"issue":"6","key":"126_CR144","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1093\/ndt\/gfx224","volume":"33","author":"E Snauwaert","year":"2018","unstructured":"Snauwaert E, Van Biesen W, Raes A, Glorieux G, Van Bogaert V, Van Hoeck K et al (2018) Concentrations of representative uraemic toxins in a healthy versus non-dialysis chronic kidney disease paediatric population. Nephrol Dial Transplant 33(6):978\u2013986","journal-title":"Nephrol Dial Transplant"},{"issue":"10","key":"126_CR145","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0240446","volume":"15","author":"J Holle","year":"2020","unstructured":"Holle J, Kirchner M, Okun J, Bayazit AK, Obrycki L, Canpolat N et al (2020) Serum indoxyl sulfate concentrations associate with progression of chronic kidney disease in children. PLoS One 15(10):e0240446","journal-title":"PLoS One"},{"issue":"6","key":"126_CR146","first-page":"4763","volume":"20","author":"K Zhu","year":"2019","unstructured":"Zhu K, Meng Q, Zhang Z, Yi T, He Y, Zheng J et al (2019) Aryl hydrocarbon receptor pathway: role, regulation and intervention in atherosclerosis therapy (Review). Mol Med Rep 20(6):4763\u20134773","journal-title":"Mol Med Rep"},{"key":"126_CR147","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3389\/fcell.2020.00185","volume":"8","author":"J Carracedo","year":"2020","unstructured":"Carracedo J, Alique M, Vida C, Bodega G, Ceprian N, Morales E et al (2020) Mechanisms of cardiovascular disorders in patients with chronic kidney disease: a process related to accelerated senescence. Front Cell Dev Biol 8:185","journal-title":"Front Cell Dev Biol"},{"issue":"14","key":"126_CR148","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1016\/j.jacc.2019.08.1017","volume":"74","author":"MJ Sarnak","year":"2019","unstructured":"Sarnak MJ, Amann K, Bangalore S, Cavalcante JL, Charytan DM, Craig JC et al (2019) Chronic kidney disease and coronary artery disease: JACC State-of-the-Art Review. J Am Coll Cardiol 74(14):1823\u20131838","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"126_CR149","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.2215\/CJN.12691117","volume":"13","author":"A Jovanovich","year":"2018","unstructured":"Jovanovich A, Isakova T, Stubbs J (2018) Microbiome and cardiovascular disease in CKD. Clin J Am Soc Nephrol 13(10):1598\u20131604","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"126_CR150","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1161\/CIRCULATIONAHA.113.002714","volume":"128","author":"H Xiao","year":"2013","unstructured":"Xiao H, Lu M, Lin TY, Chen Z, Chen G, Wang WC et al (2013) Sterol regulatory element binding protein 2 activation of NLRP3 inflammasome in endothelium mediates hemodynamic-induced atherosclerosis susceptibility. Circulation. 128(6):632\u2013642","journal-title":"Circulation."},{"issue":"1-2","key":"126_CR151","first-page":"1","volume":"72","author":"T Niwa","year":"2010","unstructured":"Niwa T (2010) Uremic toxicity of indoxyl sulfate. Nagoya J Med Sci 72(1-2):1\u201311","journal-title":"Nagoya J Med Sci"},{"issue":"10","key":"126_CR152","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1038\/sj.ki.5000340","volume":"69","author":"H Yamamoto","year":"2006","unstructured":"Yamamoto H, Tsuruoka S, Ioka T, Ando H, Ito C, Akimoto T et al (2006) Indoxyl sulfate stimulates proliferation of rat vascular smooth muscle cells. Kidney Int 69(10):1780\u20131785","journal-title":"Kidney Int"},{"issue":"12","key":"126_CR153","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1002\/jemt.23369","volume":"82","author":"X He","year":"2019","unstructured":"He X, Jiang H, Gao F, Liang S, Wei M, Chen L (2019) Indoxyl sulfate-induced calcification of vascular smooth muscle cells via the PI3K\/Akt\/NF-kappaB signaling pathway. Microsc Res Tech 82(12):2000\u20132006","journal-title":"Microsc Res Tech"},{"issue":"43","key":"126_CR154","doi-asserted-by":"publisher","first-page":"16767","DOI":"10.1073\/pnas.0808567105","volume":"105","author":"BS Samuel","year":"2008","unstructured":"Samuel BS, Shaito A, Motoike T, Rey FE, Backhed F, Manchester JK et al (2008) Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41. Proc Natl Acad Sci U S A 105(43):16767\u201316772","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"126_CR155","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.jnutbio.2010.07.009","volume":"22","author":"MA Vinolo","year":"2011","unstructured":"Vinolo MA, Rodrigues HG, Hatanaka E, Sato FT, Sampaio SC, Curi R (2011) Suppressive effect of short-chain fatty acids on production of proinflammatory mediators by neutrophils. J Nutr Biochem 22(9):849\u2013855","journal-title":"J Nutr Biochem"},{"key":"126_CR156","doi-asserted-by":"publisher","first-page":"869647","DOI":"10.5402\/2011\/869647","volume":"2011","author":"PV Licciardi","year":"2011","unstructured":"Licciardi PV, Ververis K, Karagiannis TC (2011) Histone deacetylase inhibition and dietary short-chain fatty acids. ISRN Allergy 2011:869647","journal-title":"ISRN Allergy"},{"key":"126_CR157","doi-asserted-by":"publisher","first-page":"533","DOI":"10.3389\/fphar.2018.00533","volume":"9","author":"M Li","year":"2018","unstructured":"Li M, van Esch B, Henricks PAJ, Folkerts G, Garssen J (2018) The anti-inflammatory effects of short chain fatty acids on lipopolysaccharide- or tumor necrosis factor alpha-stimulated endothelial cells via activation of GPR41\/43 and inhibition of HDACs. Front Pharmacol 9:533","journal-title":"Front Pharmacol"},{"key":"126_CR158","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/B978-0-12-800100-4.00003-9","volume":"121","author":"J Tan","year":"2014","unstructured":"Tan J, McKenzie C, Potamitis M, Thorburn AN, Mackay CR, Macia L (2014) The role of short-chain fatty acids in health and disease. Adv Immunol 121:91\u2013119","journal-title":"Adv Immunol"},{"issue":"5","key":"126_CR159","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.nutres.2008.02.012","volume":"28","author":"M Usami","year":"2008","unstructured":"Usami M, Kishimoto K, Ohata A, Miyoshi M, Aoyama M, Fueda Y et al (2008) Butyrate and trichostatin A attenuate nuclear factor kappaB activation and tumor necrosis factor alpha secretion and increase prostaglandin E2 secretion in human peripheral blood mononuclear cells. Nutr Res 28(5):321\u2013328","journal-title":"Nutr Res"},{"issue":"5535","key":"126_CR160","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1126\/science.1062374","volume":"293","author":"L Chen","year":"2001","unstructured":"Chen L, Fischle W, Verdin E, Greene WC (2001) Duration of nuclear NF-kappaB action regulated by reversible acetylation. Science. 293(5535):1653\u20131657","journal-title":"Science."},{"issue":"20","key":"126_CR161","doi-asserted-by":"publisher","first-page":"2826","DOI":"10.3748\/wjg.v13.i20.2826","volume":"13","author":"S Tedelind","year":"2007","unstructured":"Tedelind S, Westberg F, Kjerrulf M, Vidal A (2007) Anti-inflammatory properties of the short-chain fatty acids acetate and propionate: a study with relevance to inflammatory bowel disease. World J Gastroenterol 13(20):2826\u20132832","journal-title":"World J Gastroenterol"},{"issue":"11-12","key":"126_CR162","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/j.nut.2008.06.012","volume":"24","author":"M Miyoshi","year":"2008","unstructured":"Miyoshi M, Usami M, Ohata A (2008) Short-chain fatty acids and trichostatin A alter tight junction permeability in human umbilical vein endothelial cells. Nutrition. 24(11-12):1189\u20131198","journal-title":"Nutrition."},{"issue":"4","key":"126_CR163","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.nut.2007.12.013","volume":"24","author":"M Waldecker","year":"2008","unstructured":"Waldecker M, Kautenburger T, Daumann H, Veeriah S, Will F, Dietrich H et al (2008) Histone-deacetylase inhibition and butyrate formation: fecal slurry incubations with apple pectin and apple juice extracts. Nutrition. 24(4):366\u2013374","journal-title":"Nutrition."},{"issue":"7461","key":"126_CR164","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/nature12331","volume":"500","author":"K Atarashi","year":"2013","unstructured":"Atarashi K, Tanoue T, Oshima K, Suda W, Nagano Y, Nishikawa H et al (2013) Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature. 500(7461):232\u2013236","journal-title":"Nature."},{"issue":"6015","key":"126_CR165","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1126\/science.1198469","volume":"331","author":"K Atarashi","year":"2011","unstructured":"Atarashi K, Tanoue T, Shima T, Imaoka A, Kuwahara T, Momose Y et al (2011) Induction of colonic regulatory T cells by indigenous Clostridium species. Science. 331(6015):337\u2013341","journal-title":"Science."},{"issue":"7","key":"126_CR166","doi-asserted-by":"publisher","first-page":"3433","DOI":"10.4049\/jimmunol.0904028","volume":"184","author":"AM Thornton","year":"2010","unstructured":"Thornton AM, Korty PE, Tran DQ, Wohlfert EA, Murray PE, Belkaid Y et al (2010) Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells. J Immunol 184(7):3433\u20133441","journal-title":"J Immunol"},{"issue":"4","key":"126_CR167","doi-asserted-by":"publisher","first-page":"2839","DOI":"10.3390\/nu7042839","volume":"7","author":"M Kasubuchi","year":"2015","unstructured":"Kasubuchi M, Hasegawa S, Hiramatsu T, Ichimura A, Kimura I (2015) Dietary gut microbial metabolites, short-chain fatty acids, and host metabolic regulation. Nutrients. 7(4):2839\u20132849","journal-title":"Nutrients."},{"issue":"7 Suppl","key":"126_CR168","doi-asserted-by":"publisher","first-page":"2485S","DOI":"10.1093\/jn\/133.7.2485S","volume":"133","author":"JR Davie","year":"2003","unstructured":"Davie JR (2003) Inhibition of histone deacetylase activity by butyrate. J Nutr 133(7 Suppl):2485S\u20132493S","journal-title":"J Nutr"},{"issue":"3","key":"126_CR169","doi-asserted-by":"publisher","first-page":"173","DOI":"10.5483\/BMBRep.2014.47.3.272","volume":"47","author":"S Kim","year":"2014","unstructured":"Kim S, Kim JH, Park BO, Kwak YS (2014) Perspectives on the therapeutic potential of short-chain fatty acid receptors. BMB Rep 47(3):173\u2013178","journal-title":"BMB Rep"},{"issue":"11","key":"126_CR170","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1248\/bpb.b13-00312","volume":"36","author":"SU Lee","year":"2013","unstructured":"Lee SU, In HJ, Kwon MS, Park BO, Jo M, Kim MO et al (2013) beta-Arrestin 2 mediates G protein-coupled receptor 43 signals to nuclear factor-kappaB. Biol Pharm Bull 36(11):1754\u20131759","journal-title":"Biol Pharm Bull"},{"issue":"28","key":"126_CR171","doi-asserted-by":"publisher","first-page":"25481","DOI":"10.1074\/jbc.M301403200","volume":"278","author":"E Le Poul","year":"2003","unstructured":"Le Poul E, Loison C, Struyf S, Springael JY, Lannoy V, Decobecq ME et al (2003) Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation. J Biol Chem 278(28):25481\u201325489","journal-title":"J Biol Chem"},{"key":"126_CR172","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3389\/fendo.2012.00111","volume":"3","author":"T Ulven","year":"2012","unstructured":"Ulven T (2012) Short-chain free fatty acid receptors FFA2\/GPR43 and FFA3\/GPR41 as new potential therapeutic targets. Front Endocrinol (Lausanne) 3:111","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5","key":"126_CR173","doi-asserted-by":"publisher","first-page":"425","DOI":"10.5551\/jat.15065","volume":"20","author":"H Ohira","year":"2013","unstructured":"Ohira H, Fujioka Y, Katagiri C, Mamoto R, Aoyama-Ishikawa M, Amako K et al (2013) Butyrate attenuates inflammation and lipolysis generated by the interaction of adipocytes and macrophages. J Atheroscler Thromb 20(5):425\u2013442","journal-title":"J Atheroscler Thromb"},{"issue":"1","key":"126_CR174","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00535-016-1242-9","volume":"52","author":"M Sun","year":"2017","unstructured":"Sun M, Wu W, Liu Z, Cong Y (2017) Microbiota metabolite short chain fatty acids, GPCR, and inflammatory bowel diseases. J Gastroenterol 52(1):1\u20138","journal-title":"J Gastroenterol"},{"issue":"11","key":"126_CR175","doi-asserted-by":"publisher","first-page":"7514","DOI":"10.4049\/jimmunol.0900063","volume":"183","author":"C Sina","year":"2009","unstructured":"Sina C, Gavrilova O, Forster M, Till A, Derer S, Hildebrand F et al (2009) G protein-coupled receptor 43 is essential for neutrophil recruitment during intestinal inflammation. J Immunol 183(11):7514\u20137522","journal-title":"J Immunol"},{"issue":"6","key":"126_CR176","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.numecd.2014.01.002","volume":"24","author":"EC Aguilar","year":"2014","unstructured":"Aguilar EC, Leonel AJ, Teixeira LG, Silva AR, Silva JF, Pelaez JM et al (2014) Butyrate impairs atherogenesis by reducing plaque inflammation and vulnerability and decreasing NFkappaB activation. Nutr Metab Cardiovasc Dis 24(6):606\u2013613","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"5","key":"126_CR177","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s11883-013-0325-9","volume":"15","author":"JT Chai","year":"2013","unstructured":"Chai JT, Digby JE, Choudhury RP (2013) GPR109A and vascular inflammation. Curr Atheroscler Rep 15(5):325","journal-title":"Curr Atheroscler Rep"},{"issue":"3","key":"126_CR178","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1161\/ATVBAHA.111.241836","volume":"32","author":"JE Digby","year":"2012","unstructured":"Digby JE, Martinez F, Jefferson A, Ruparelia N, Chai J, Wamil M et al (2012) Anti-inflammatory effects of nicotinic acid in human monocytes are mediated by GPR109A dependent mechanisms. Arterioscler Thromb Vasc Biol 32(3):669\u2013676","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"11","key":"126_CR179","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/nri2653","volume":"9","author":"JR Turner","year":"2009","unstructured":"Turner JR (2009) Intestinal mucosal barrier function in health and disease. Nat Rev Immunol 9(11):799\u2013809","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"126_CR180","doi-asserted-by":"publisher","first-page":"G851","DOI":"10.1152\/ajpgi.2000.279.5.G851","volume":"279","author":"A Nusrat","year":"2000","unstructured":"Nusrat A, Turner JR, Madara JL (2000) Molecular physiology and pathophysiology of tight junctions. IV. Regulation of tight junctions by extracellular stimuli: nutrients, cytokines, and immune cells. Am J Physiol Gastrointest Liver Physiol 279(5):G851\u2013G857","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"17","key":"126_CR181","doi-asserted-by":"publisher","first-page":"3930","DOI":"10.1091\/mbc.e09-04-0320","volume":"20","author":"CM Van Itallie","year":"2009","unstructured":"Van Itallie CM, Fanning AS, Bridges A, Anderson JM (2009) ZO-1 stabilizes the tight junction solute barrier through coupling to the perijunctional cytoskeleton. Mol Biol Cell 20(17):3930\u20133940","journal-title":"Mol Biol Cell"},{"issue":"8","key":"126_CR182","first-page":"608","volume":"80","author":"ND Vaziri","year":"1985","unstructured":"Vaziri ND, Dure-Smith B, Miller R, Mirahmadi MK (1985) Pathology of gastrointestinal tract in chronic hemodialysis patients: an autopsy study of 78 cases. Am J Gastroenterol 80(8):608\u2013611","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"126_CR183","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1007\/s00240-003-0381-7","volume":"32","author":"JB de Almeida Duarte","year":"2004","unstructured":"de Almeida Duarte JB, de Aguilar-Nascimento JE, Nascimento M, Nochi RJ Jr (2004) Bacterial translocation in experimental uremia. Urol Res 32(4):266\u2013270","journal-title":"Urol Res"},{"issue":"11","key":"126_CR184","doi-asserted-by":"publisher","first-page":"2856","DOI":"10.1007\/s10620-012-2242-0","volume":"57","author":"F Wang","year":"2012","unstructured":"Wang F, Zhang P, Jiang H, Cheng S (2012) Gut bacterial translocation contributes to microinflammation in experimental uremia. Dig Dis Sci 57(11):2856\u20132862","journal-title":"Dig Dis Sci"},{"issue":"5","key":"126_CR185","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1159\/000343886","volume":"36","author":"ND Vaziri","year":"2012","unstructured":"Vaziri ND, Goshtasbi N, Yuan J, Jellbauer S, Moradi H, Raffatellu M et al (2012) Uremic plasma impairs barrier function and depletes the tight junction protein constituents of intestinal epithelium. Am J Nephrol 36(5):438\u2013443","journal-title":"Am J Nephrol"},{"issue":"1","key":"126_CR186","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000345969","volume":"37","author":"ND Vaziri","year":"2013","unstructured":"Vaziri ND, Yuan J, Norris K (2013) Role of urea in intestinal barrier dysfunction and disruption of epithelial tight junction in chronic kidney disease. Am J Nephrol 37(1):1\u20136","journal-title":"Am J Nephrol"},{"issue":"6","key":"126_CR187","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1159\/000351171","volume":"37","author":"ND Vaziri","year":"2013","unstructured":"Vaziri ND, Yuan J, Khazaeli M, Masuda Y, Ichii H, Liu S (2013) Oral activated charcoal adsorbent (AST-120) ameliorates chronic kidney disease-induced intestinal epithelial barrier disruption. Am J Nephrol 37(6):518\u2013525","journal-title":"Am J Nephrol"},{"issue":"5","key":"126_CR188","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/S1388-9842(03)00104-1","volume":"5","author":"T Peschel","year":"2003","unstructured":"Peschel T, Schonauer M, Thiele H, Anker SD, Schuler G, Niebauer J (2003) Invasive assessment of bacterial endotoxin and inflammatory cytokines in patients with acute heart failure. Eur J Heart Fail 5(5):609\u2013614","journal-title":"Eur J Heart Fail"},{"issue":"5","key":"126_CR189","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1097\/MCO.0b013e32830a4c6e","volume":"11","author":"A Sandek","year":"2008","unstructured":"Sandek A, Rauchhaus M, Anker SD, von Haehling S (2008) The emerging role of the gut in chronic heart failure. Curr Opin Clin Nutr Metab Care 11(5):632\u2013639","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"5","key":"126_CR190","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1053\/j.ajkd.2012.05.020","volume":"60","author":"UG Rossi","year":"2012","unstructured":"Rossi UG, Petrocelli F, Seitun S, Ferro C (2012) Nonocclusive mesenteric ischemia in a dialysis patient with extensive vascular calcification. Am J Kidney Dis 60(5):843\u2013846","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"126_CR191","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/0002-9343(85)90546-7","volume":"79","author":"SL Gerson","year":"1985","unstructured":"Gerson SL, Talbot GH, Hurwitz S, Lusk EJ, Strom BL, Cassileth PA (1985) Discriminant scorecard for diagnosis of invasive pulmonary aspergillosis in patients with acute leukemia. Am J Med 79(1):57\u201364","journal-title":"Am J Med"},{"issue":"2","key":"126_CR192","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/S0002-9440(10)62264-X","volume":"166","author":"F Wang","year":"2005","unstructured":"Wang F, Graham WV, Wang Y, Witkowski ED, Schwarz BT, Turner JR (2005) Interferon-gamma and tumor necrosis factor-alpha synergize to induce intestinal epithelial barrier dysfunction by up-regulating myosin light chain kinase expression. Am J Pathol 166(2):409\u2013419","journal-title":"Am J Pathol"},{"issue":"3","key":"126_CR193","doi-asserted-by":"publisher","first-page":"F662","DOI":"10.1152\/ajprenal.00421.2009","volume":"298","author":"HJ Kim","year":"2010","unstructured":"Kim HJ, Vaziri ND (2010) Contribution of impaired Nrf2-Keap1 pathway to oxidative stress and inflammation in chronic renal failure. Am J Physiol Ren Physiol 298(3):F662\u2013F671","journal-title":"Am J Physiol Ren Physiol"},{"issue":"5","key":"126_CR194","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1042\/CS20171107","volume":"132","author":"WL Lau","year":"2018","unstructured":"Lau WL, Savoj J, Nakata MB, Vaziri ND (2018) Altered microbiome in chronic kidney disease: systemic effects of gut-derived uremic toxins. Clin Sci (Lond) 132(5):509\u2013522","journal-title":"Clin Sci (Lond)"},{"issue":"2","key":"126_CR195","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1093\/ckj\/sfv004","volume":"8","author":"R Vanholder","year":"2015","unstructured":"Vanholder R, Glorieux G (2015) The intestine and the kidneys: a bad marriage can be hazardous. Clin Kidney J 8(2):168\u2013179","journal-title":"Clin Kidney J"},{"key":"126_CR196","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.1038\/ki.2009.402","volume":"114","author":"P Evenepoel","year":"2009","unstructured":"Evenepoel P, Meijers BK, Bammens BR, Verbeke K (2009) Uremic toxins originating from colonic microbial metabolism. Kidney Int Suppl 114:S12\u2013S19","journal-title":"Kidney Int Suppl"},{"key":"126_CR197","doi-asserted-by":"publisher","unstructured":"Banerjee T, Carrero JJ, McCulloch C et al (2021) Dietary factors and prevention: risk of end-stage kidney disease by fruit and vegetable consumption. Am J Nephrol\u00a052(5):356\u2013367. https:\/\/doi.org\/10.1159\/000514754","DOI":"10.1159\/000514754"},{"issue":"4","key":"126_CR198","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1053\/j.jrn.2019.09.008","volume":"30","author":"J Heindel","year":"2020","unstructured":"Heindel J, Baid-Agrawal S, Rebholz CM, Nadal J, Schmid M, Schaeffner E et al (2020) Association between dietary patterns and kidney function in patients with chronic kidney disease: a cross-sectional analysis of the German Chronic Kidney Disease Study. J Ren Nutr 30(4):296\u2013304","journal-title":"J Ren Nutr"},{"issue":"8","key":"126_CR199","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/nrgastro.2017.75","volume":"14","author":"GR Gibson","year":"2017","unstructured":"Gibson GR, Hutkins R, Sanders ME, Prescott SL, Reimer RA, Salminen SJ et al (2017) Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nat Rev Gastroenterol Hepatol 14(8):491\u2013502","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"126_CR200","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1093\/ndt\/gfp414","volume":"25","author":"BK Meijers","year":"2010","unstructured":"Meijers BK, De Preter V, Verbeke K, Vanrenterghem Y, Evenepoel P (2010) p-Cresyl sulfate serum concentrations in haemodialysis patients are reduced by the prebiotic oligofructose-enriched inulin. Nephrol Dial Transplant 25(1):219\u2013224","journal-title":"Nephrol Dial Transplant"},{"key":"126_CR201","doi-asserted-by":"publisher","unstructured":"Marzocco S, Fazeli G, Di Micco L et al\u00a0(2018) Supplementation of short-chain fatty acid, sodium propionate, in patients on maintenance hemodialysis: beneficial effects on inflammatory parameters and gut-derived uremic toxins, a pilot study (PLAN Study). J Clin Med\u00a07(10). https:\/\/doi.org\/10.3390\/jcm7100315","DOI":"10.3390\/jcm7100315"},{"key":"126_CR202","doi-asserted-by":"publisher","unstructured":"El Amouri A, Snauwaert E, Foulon A, Vande Moortel C, Van Dyck M, Van Hoeck K et al (2021) Dietary fibre intake is associated with serum levels of uraemic toxins in children with chronic kidney disease. Toxins\u00a0 13:225. https:\/\/doi.org\/10.3390\/toxins13030225","DOI":"10.3390\/toxins13030225"},{"issue":"3","key":"126_CR203","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1053\/j.jrn.2018.08.008","volume":"29","author":"C McFarlane","year":"2019","unstructured":"McFarlane C, Ramos CI, Johnson DW, Campbell KL (2019) Prebiotic, probiotic, and synbiotic supplementation in chronic kidney disease: a systematic review and meta-analysis. J Ren Nutr 29(3):209\u2013220","journal-title":"J Ren Nutr"},{"issue":"2","key":"126_CR204","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/j.1744-9987.2010.00891.x","volume":"15","author":"S Goto","year":"2011","unstructured":"Goto S, Yoshiya K, Kita T, Fujii H, Fukagawa M (2011) Uremic toxins and oral adsorbents. Ther Apher Dial 15(2):132\u2013134","journal-title":"Ther Apher Dial"},{"issue":"1","key":"126_CR205","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s12882-016-0357-9","volume":"17","author":"G Schulman","year":"2016","unstructured":"Schulman G, Berl T, Beck GJ, Remuzzi G, Ritz E, Shimizu M et al (2016) The effects of AST-120 on chronic kidney disease progression in the United States of America: a post hoc subgroup analysis of randomized controlled trials. BMC Nephrol 17(1):141","journal-title":"BMC Nephrol"},{"key":"126_CR206","doi-asserted-by":"publisher","unstructured":"Liu W-C, Tomino Y, Lu K-C\u00a0(2018) Impacts of indoxyl sulfate and p-cresol sulfate on chronic kidney disease and mitigating effects of AST-120. Toxins 10(9):367. https:\/\/doi.org\/10.3390\/toxins10090367","DOI":"10.3390\/toxins10090367"},{"issue":"9","key":"126_CR207","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1042\/CS20080642","volume":"117","author":"MA Vinolo","year":"2009","unstructured":"Vinolo MA, Rodrigues HG, Hatanaka E, Hebeda CB, Farsky SH, Curi R (2009) Short-chain fatty acids stimulate the migration of neutrophils to inflammatory sites. Clin Sci (Lond) 117(9):331\u2013338","journal-title":"Clin Sci (Lond)"},{"issue":"12","key":"126_CR208","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1038\/nrd3031","volume":"8","author":"L Wang","year":"2009","unstructured":"Wang L, de Zoeten EF, Greene MI, Hancock WW (2009) Immunomodulatory effects of deacetylase inhibitors: therapeutic targeting of FOXP3+ regulatory T cells. Nat Rev Drug Discov 8(12):969\u2013981","journal-title":"Nat Rev Drug Discov"},{"issue":"4","key":"126_CR209","doi-asserted-by":"publisher","first-page":"196","DOI":"10.3109\/10799893.2012.692118","volume":"32","author":"S Seljeset","year":"2012","unstructured":"Seljeset S, Siehler S (2012) Receptor-specific regulation of ERK1\/2 activation by members of the \u201cfree fatty acid receptor\u201d family. J Recept Signal Transduct Res 32(4):196\u2013201","journal-title":"J Recept Signal Transduct Res"},{"issue":"2","key":"126_CR210","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1053\/j.gastro.2013.04.056","volume":"145","author":"MH Kim","year":"2013","unstructured":"Kim MH, Kang SG, Park JH, Yanagisawa M, Kim CH (2013) Short-chain fatty acids activate GPR41 and GPR43 on intestinal epithelial cells to promote inflammatory responses in mice. Gastroenterology 145(2):396\u2013406 e1-10","journal-title":"Gastroenterology"},{"issue":"4","key":"126_CR211","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1182\/blood-2010-05-284711","volume":"117","author":"T Roger","year":"2011","unstructured":"Roger T, Lugrin J, Le Roy D, Goy G, Mombelli M, Koessler T et al (2011) Histone deacetylase inhibitors impair innate immune responses to Toll-like receptor agonists and to infection. Blood. 117(4):1205\u20131217","journal-title":"Blood."},{"issue":"4","key":"126_CR212","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1189\/jlb.1013565","volume":"95","author":"Y Jeong","year":"2014","unstructured":"Jeong Y, Du R, Zhu X, Yin S, Wang J, Cui H et al (2014) Histone deacetylase isoforms regulate innate immune responses by deacetylating mitogen-activated protein kinase phosphatase-1. J Leukoc Biol 95(4):651\u2013659","journal-title":"J Leukoc Biol"},{"issue":"20","key":"126_CR213","doi-asserted-by":"publisher","first-page":"7065","DOI":"10.1128\/MCB.21.20.7065-7077.2001","volume":"21","author":"BP Ashburner","year":"2001","unstructured":"Ashburner BP, Westerheide SD, Baldwin AS Jr (2001) The p65 (RelA) subunit of NF-kappaB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression. Mol Cell Biol 21(20):7065\u20137077","journal-title":"Mol Cell Biol"},{"issue":"6","key":"126_CR214","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1002\/hep.23572","volume":"51","author":"SF Kendrick","year":"2010","unstructured":"Kendrick SF, O'Boyle G, Mann J, Zeybel M, Palmer J, Jones DE et al (2010) Acetate, the key modulator of inflammatory responses in acute alcoholic hepatitis. Hepatology. 51(6):1988\u20131997","journal-title":"Hepatology."},{"issue":"6","key":"126_CR215","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/s41419-021-03880-9","volume":"12","author":"F Zou","year":"2021","unstructured":"Zou F, Qiu Y, Huang Y, Zou H, Cheng X, Niu Q et al (2021) Effects of short-chain fatty acids in inhibiting HDAC and activating p38 MAPK are critical for promoting B10 cell generation and function. Cell Death Dis 12(6):582","journal-title":"Cell Death Dis"},{"issue":"7480","key":"126_CR216","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/nature12726","volume":"504","author":"N Arpaia","year":"2013","unstructured":"Arpaia N, Campbell C, Fan X, Dikiy S, van der Veeken J, de Roos P et al (2013) Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature. 504(7480):451\u2013455","journal-title":"Nature."},{"issue":"1-2","key":"126_CR217","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.cellimm.2009.03.004","volume":"257","author":"JL Lucas","year":"2009","unstructured":"Lucas JL, Mirshahpanah P, Haas-Stapleton E, Asadullah K, Zollner TM, Numerof RP (2009) Induction of Foxp3+ regulatory T cells with histone deacetylase inhibitors. Cell Immunol 257(1-2):97\u2013104","journal-title":"Cell Immunol"},{"issue":"11","key":"126_CR218","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1038\/nm1652","volume":"13","author":"R Tao","year":"2007","unstructured":"Tao R, de Zoeten EF, Ozkaynak E, Chen C, Wang L, Porrett PM et al (2007) Deacetylase inhibition promotes the generation and function of regulatory T cells. Nat Med 13(11):1299\u20131307","journal-title":"Nat Med"},{"issue":"3","key":"126_CR219","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.clim.2010.04.018","volume":"136","author":"T Akimova","year":"2010","unstructured":"Akimova T, Ge G, Golovina T, Mikheeva T, Wang L, Riley JL et al (2010) Histone\/protein deacetylase inhibitors increase suppressive functions of human FOXP3+ Tregs. Clin Immunol 136(3):348\u2013363","journal-title":"Clin Immunol"},{"issue":"11","key":"126_CR220","doi-asserted-by":"publisher","first-page":"4571","DOI":"10.1073\/pnas.0700298104","volume":"104","author":"B Li","year":"2007","unstructured":"Li B, Samanta A, Song X, Iacono KT, Bembas K, Tao R et al (2007) FOXP3 interactions with histone acetyltransferase and class II histone deacetylases are required for repression. Proc Natl Acad Sci U S A 104(11):4571\u20134576","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"126_CR221","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/nm.3444","volume":"20","author":"A Trompette","year":"2014","unstructured":"Trompette A, Gollwitzer ES, Yadava K, Sichelstiel AK, Sprenger N, Ngom-Bru C et al (2014) Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Nat Med 20(2):159\u2013166","journal-title":"Nat Med"},{"issue":"7","key":"126_CR222","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1111\/j.1460-9568.2009.06895.x","volume":"30","author":"T Tazoe","year":"2009","unstructured":"Tazoe T, Sakamoto M, Nakajima T, Endoh T, Shiozawa S, Komiyama T (2009) Remote facilitation of supraspinal motor excitability depends on the level of effort. Eur J Neurosci 30(7):1297\u20131305","journal-title":"Eur J Neurosci"},{"issue":"48","key":"126_CR223","doi-asserted-by":"publisher","first-page":"44641","DOI":"10.1074\/jbc.M105170200","volume":"276","author":"L Yin","year":"2001","unstructured":"Yin L, Laevsky G, Giardina C (2001) Butyrate suppression of colonocyte NF-kappa B activation and cellular proteasome activity. J Biol Chem 276(48):44641\u201344646","journal-title":"J Biol Chem"},{"issue":"6","key":"126_CR224","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.nut.2009.07.006","volume":"26","author":"M Aoyama","year":"2010","unstructured":"Aoyama M, Kotani J, Usami M (2010) Butyrate and propionate induced activated or non-activated neutrophil apoptosis via HDAC inhibitor activity but without activating GPR-41\/GPR-43 pathways. Nutrition. 26(6):653\u2013661","journal-title":"Nutrition."},{"issue":"7268","key":"126_CR225","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1038\/nature08530","volume":"461","author":"KM Maslowski","year":"2009","unstructured":"Maslowski KM, Vieira AT, Ng A, Kranich J, Sierro F, Yu D et al (2009) Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature. 461(7268):1282\u20131286","journal-title":"Nature."},{"issue":"4","key":"126_CR226","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.jnutbio.2003.11.008","volume":"15","author":"D Zapolska-Downar","year":"2004","unstructured":"Zapolska-Downar D, Siennicka A, Kaczmarczyk M, Kolodziej B, Naruszewicz M (2004) Butyrate inhibits cytokine-induced VCAM-1 and ICAM-1 expression in cultured endothelial cells: the role of NF-kappaB and PPARalpha. J Nutr Biochem 15(4):220\u2013228","journal-title":"J Nutr Biochem"},{"issue":"1","key":"126_CR227","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1002\/cbf.1533","volume":"27","author":"MA Vinolo","year":"2009","unstructured":"Vinolo MA, Hatanaka E, Lambertucci RH, Newsholme P, Curi R (2009) Effects of short chain fatty acids on effector mechanisms of neutrophils. Cell Biochem Funct 27(1):48\u201355","journal-title":"Cell Biochem Funct"},{"issue":"2","key":"126_CR228","doi-asserted-by":"publisher","first-page":"364","DOI":"10.2337\/db11-1019","volume":"61","author":"G Tolhurst","year":"2012","unstructured":"Tolhurst G, Heffron H, Lam YS, Parker HE, Habib AM, Diakogiannaki E et al (2012) Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2. Diabetes. 61(2):364\u2013371","journal-title":"Diabetes."},{"issue":"3","key":"126_CR229","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.immuni.2010.03.003","volume":"32","author":"MH Zaki","year":"2010","unstructured":"Zaki MH, Boyd KL, Vogel P, Kastan MB, Lamkanfi M, Kanneganti TD (2010) The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis. Immunity. 32(3):379\u2013391","journal-title":"Immunity."},{"issue":"9","key":"126_CR230","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1111\/jcmm.12595","volume":"19","author":"L Poralla","year":"2015","unstructured":"Poralla L, Stroh T, Erben U, Sittig M, Liebig S, Siegmund B et al (2015) Histone deacetylase 5 regulates the inflammatory response of macrophages. J Cell Mol Med 19(9):2162\u20132171","journal-title":"J Cell Mol Med"},{"issue":"3","key":"126_CR231","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1172\/JCI41651","volume":"121","author":"M Lukasova","year":"2011","unstructured":"Lukasova M, Malaval C, Gille A, Kero J, Offermanns S (2011) Nicotinic acid inhibits progression of atherosclerosis in mice through its receptor GPR109A expressed by immune cells. J Clin Invest 121(3):1163\u20131173","journal-title":"J Clin Invest"},{"issue":"1","key":"126_CR232","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.immuni.2013.12.007","volume":"40","author":"N Singh","year":"2014","unstructured":"Singh N, Gurav A, Sivaprakasam S, Brady E, Padia R, Shi H et al (2014) Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis. Immunity. 40(1):128\u2013139","journal-title":"Immunity."}],"container-title":["Molecular and Cellular Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40348-021-00126-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40348-021-00126-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40348-021-00126-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,25]],"date-time":"2021-10-25T23:11:33Z","timestamp":1635203493000},"score":1,"resource":{"primary":{"URL":"https:\/\/molcellped.springeropen.com\/articles\/10.1186\/s40348-021-00126-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,22]]},"references-count":232,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["126"],"URL":"https:\/\/doi.org\/10.1186\/s40348-021-00126-8","relation":{},"ISSN":["2194-7791"],"issn-type":[{"value":"2194-7791","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,22]]},"assertion":[{"value":"28 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17"}}